Home/Filings/4/0001396814-24-000135
4//SEC Filing

Cross Shawn 4

Accession 0001396814-24-000135

CIK 0001396814other

Filed

Nov 4, 7:00 PM ET

Accepted

Nov 5, 4:42 PM ET

Size

7.6 KB

Accession

0001396814-24-000135

Insider Transaction Report

Form 4
Period: 2024-11-01
Cross Shawn
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-11-04+200,000200,000 total
    Exercise: $16.45Exp: 2034-11-04Common Stock (200,000 underlying)
  • Award

    Common Stock

    2024-11-01+75,00075,000 total
Footnotes (2)
  • [F1]Represents restricted stock units that vest in four equal annual installments beginning on November 1, 2025, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.
  • [F2]The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.

Issuer

Pacira BioSciences, Inc.

CIK 0001396814

Entity typeother

Related Parties

1
  • filerCIK 0001734779

Filing Metadata

Form type
4
Filed
Nov 4, 7:00 PM ET
Accepted
Nov 5, 4:42 PM ET
Size
7.6 KB